TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/28/23 17:28 | 8/24/23 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Powell Ann | NJ | O | EVP,Chie | S | -1,102 | 61.25 | 0 | -18 | -39 | 28 | D | ||||||||||||||
3/14/23 20:18 | 3/10/23 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Powell Ann | NY | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 34 | 302 | 46 | D | ||||||||||||||
2/8/23 20:09 | 2/6/23 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Powell Ann | NY | O | EVP,Chie | S | -835 | 74.69 | 0 | -11 | -33 | 23 | D | ||||||||||||||
11/14/22 18:57 | 11/9/22 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Powell Ann | NY | O | EVP,Chie | S | -1,307 | 80.45 | 0 | -16 | -32 | 34 | D | ||||||||||||||
9/15/22 19:29 | 9/14/22 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Powell Ann | NY | O | EVP,Chie | S | -1,769 | 70.75 | 0 | -25 | -33 | 50 | D | ||||||||||||||
3/14/22 21:17 | 3/10/22 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Powell Ann | NY | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 36 | 90 | 75 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |